Suchergebnisse - "Sprague, Stuart M"

PubPharm (25)

1

Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis

enthalten in: American journal of nephrology | 2024

von Medaura, J. | Zhou, M. | Ficociello, L. | +2

2

Sucroferric oxyhydroxide for hyperphosphatemia : a review of real-world evidence

enthalten in: Journal of nephrology | 2022

von Coyne, D. | Sprague, S. | Vervloet, M. | +2

3

Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence

enthalten in: Journal of nephrology | 2022

von Coyne, D. | Sprague, S. | Vervloet, M. | +2

4

Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence

enthalten in: Journal of nephrology | 2022

von Coyne, D. | Sprague, S. | Vervloet, M. | +2

5

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate : A post hoc Analysis of a Phase 3 Study

enthalten in: Nephron | 2020

von Covic, A. | Sprague, S. | Rastogi, A. | +4

6

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2019

von Ketteler, M. | Sprague, S. | Covic, A. | +5

7

Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis : A retrospective analysis of pharmacy data 

enthalten in: Clinical nephrology | 2017

von Coyne, D. | Ficociello, L. | Parameswaran, V. | +7

8

Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low

enthalten in: Journal of nephrology | 2016

von Ennis, J. | Worcester, E. | Coe, F. | +1

9

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

enthalten in: American journal of nephrology | 2016

von Sprague, S. | Crawford, P. | Melnick, J. | +6

10

Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low

enthalten in: Journal of nephrology / Supplement | 2016

von Worcester, E. | Ennis, J. | Sprague, S. | +1